In our investigation, we aimed to evaluate the prognostic significance of the preoperative platelet count and C-reactive protein (P-CRP) product in non-muscle invasive bladder cancer (NMIBC) patients and to develop a Nomogram to predict recurrence-free survival (RFS) post-transurethral resection of bladder tumors (TURBT). The gene discussed is CRP; the disease is urinary bladder neoplasm.